Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

PPH VanEck Vectors Pharmaceutical ETF

  • Fund Description

    VanEck Vectors Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 09/27/16

    • 30-Day SEC Yield1

      1.82%
    • Total Net Assets

      $237.5M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.36%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      09/30/2016
  • Portfolio Composition (%)
    as of 09/27/16

    • % of Net Assets
    • Stocks

      99.82
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.18
  • Download All HoldingsDaily Holdings (%) as of 09/27/16

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Astrazeneca Plc
    AZN US
    360,588
    12,119,3635.10
    Novartis Ag
    NVS US
    148,884
    12,041,7385.07
    Johnson & Johnson
    JNJ US
    100,027
    11,925,2195.02
    Merck & Co Inc
    MRK US
    190,302
    11,907,1965.01
    Abbvie Inc
    ABBV US
    184,152
    11,890,6955.01
    Glaxosmithkline Plc
    GSK US
    273,033
    11,827,7904.98
    Bristol-Myers Squibb Co
    BMY US
    211,495
    11,788,7314.96
    Pfizer Inc
    PFE US
    343,407
    11,617,4594.89
    Sanofi
    SNY US
    302,129
    11,526,2214.85
    Novo Nordisk A/S
    NVO US
    260,717
    11,432,4404.81
    Shire Plc
    SHPG US
    55,619
    11,136,0364.69
    Eli Lilly & Co
    LLY US
    137,013
    11,081,6114.67
    Mylan Nv
    MYL US
    267,126
    11,034,9754.65
    Abbott Laboratories
    ABT US
    256,990
    10,878,3874.58
    Perrigo Co Plc
    PRGO US
    111,965
    10,834,8534.56
    Zoetis Inc
    ZTS US
    206,915
    10,732,6814.52
    Teva Pharmaceutical Industries Ltd
    TEVA US
    209,941
    10,385,7814.37
    Amerisourcebergen Corp
    ABC US
    122,711
    10,215,6914.30
    Mckesson Corp
    MCK US
    58,217
    9,684,9804.08
    Valeant Pharmaceuticals International I
    VRX US
    279,786
    7,352,7763.10
    Mallinckrodt Plc
    MNK US
    60,270
    4,293,0321.81
    Jazz Pharmaceuticals Plc
    JAZZ US
    32,119
    4,043,4611.70
    Gw Pharmaceuticals Plc
    GWPH US
    24,262
    3,030,5661.28
    Endo International Plc
    ENDP US
    109,605
    2,469,4011.04
    Akorn Inc
    AKRX US
    65,657
    1,823,9510.77
    Other/Cash
    --
    --
    435,4380.18
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.